Skip to main content
. 2013 Aug 6;4(9):1388–1398. doi: 10.18632/oncotarget.1239

Figure 2. miR-27a* transfection decreases cell viability in HNSCC cells and other solid tumor types.

Figure 2

(A) Cell viability is decreased at in three HNSCC cell lines after transfection of miR-27a* compared to miR-27a, −7, and -Control, *p<0.001; (B) Photomicrograph details cell number 72 hrs after transfection of miR-27a* mimic into wells containing 20,000 cells each; (C) Cell viability is decreased in other solid tumor cell lines (PC3 prostate, HEC1A endometrial, MIA PaCa pancreas, and MDA-468 breast) after transfection of miR-27a* compared to miR-27a, −7, and -Control, *p<0.001.